Dr. Drew Pinsky says Presley Gerber’s case exposes the danger of patients directing addiction care, while experts warn that relapse during or after rehabilitation can become fatal as tolerance falls. Gerber’s final toxicology results remained pending.
Hundreds of consumers are suing GLP-1 drug manufacturers over alleged links to NAION, a rare form of sudden vision loss, as researchers and regulators continue examining evidence that has not established the medications as a cause.
A coroner concluded that preventive anticoagulants likely could have saved Lady Joan Branson after her fracture and immobility placed her at very high risk for a deadly blood clot that traveled to her lungs.
Reports suggest GLP-1 medications are entering sorority recruitment culture as some college women pursue extreme thinness, prompting warnings about muscle loss, reproductive considerations, mental health and the unknown consequences of beginning treatment at a normal body weight.
As demand for testosterone rises among menopausal women, doctors are navigating insurance denials, compounded creams and carefully measured male products while federal regulators examine the evidence, safety concerns and need for standardized treatment.
An injectable made from sterilized donor fat promises fast volume with little downtime, but Dr. Tommaso Addona says limited human evidence and possible imaging complications make breast use too uncertain until studies track outcomes for years.
After losing Connie Dahl to stage 4 ovarian cancer, Becky Drexler faced her own diagnosis, multiple recurrences and years of treatment, while urging women not to dismiss persistent, vague symptoms and to advocate for medical evaluation.